[{"address1": "16 Abba Hillel Road", "city": "Ramat Gan", "zip": "5250608", "country": "Israel", "phone": "972 3 693 8448", "fax": "972 3 693 8447", "website": "https://galmedpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule for the treatment of non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study for HIV-associated lipodystrophy and non-alcoholic fatty liver disease. In addition, it develops products for cardiometabolic indications. The company has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with Virginia Commonwealth University to investigate the effect of adding Aramchol to prevent drug resistance to standard-of-care oncology agents in the treatment of hepatoma, cholangiocarcinoma, and colorectal cancer. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Allen  Baharaff", "age": 59, "title": "Co-Founder, President, CEO & Chairman", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1467116, "exercisedValue": 0, "unexercisedValue": 4940}, {"maxAge": 1, "name": "Mr. Doron  Cohen", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 252093, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Guy  Nehemya", "age": 39, "title": "COO & Data Protection Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 294347, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yohai  Stenzler CPA", "age": 41, "title": "Chief Accounting Officer", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 298107, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Liat  Hayardeny MBA, Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tali  Gorfine", "age": 54, "title": "Medical Consultant", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 202763, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.43, "open": 1.41, "dayLow": 1.3801, "dayHigh": 1.46, "regularMarketPreviousClose": 1.43, "regularMarketOpen": 1.41, "regularMarketDayLow": 1.3801, "regularMarketDayHigh": 1.46, "payoutRatio": 0.0, "beta": 0.491, "forwardPE": -1.3883495, "volume": 176220, "regularMarketVolume": 176220, "averageVolume": 2409149, "averageVolume10days": 274690, "averageDailyVolume10Day": 274690, "bid": 1.4, "ask": 1.45, "bidSize": 2, "askSize": 2, "marketCap": 3228982, "fiftyTwoWeekLow": 1.15, "fiftyTwoWeekHigh": 23.8, "fiftyDayAverage": 1.4498, "twoHundredDayAverage": 2.965015, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -12500011, "profitMargins": 0.0, "floatShares": 2015115, "sharesOutstanding": 2258030, "sharesShort": 188196, "sharesShortPriorMonth": 96430, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.0833, "heldPercentInsiders": 0.028959999, "heldPercentInstitutions": 0.025510002, "shortRatio": 0.04, "shortPercentOfFloat": 0.0859, "impliedSharesOutstanding": 2265960, "bookValue": 7.474, "priceToBook": 0.19132994, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -7346000, "trailingEps": -6.6, "forwardEps": -1.03, "lastSplitFactor": "1:12", "lastSplitDate": 1724976000, "enterpriseToEbitda": 2.067, "52WeekChange": -0.66713226, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 1.43, "recommendationKey": "none", "totalCash": 15729000, "totalCashPerShare": 6.966, "ebitda": -6046250, "totalDebt": 0, "quickRatio": 8.952, "currentRatio": 9.019, "returnOnAssets": -0.23118, "returnOnEquity": -0.49580002, "freeCashflow": -3822375, "operatingCashflow": -5217000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GLMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "postMarketChangePercent": 0.678326, "postMarketPrice": 1.4397, "postMarketChange": 0.00970006, "regularMarketChange": 0.0, "regularMarketDayRange": "1.3801 - 1.46", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2409149, "fiftyTwoWeekLowChange": 0.27999997, "fiftyTwoWeekLowChangePercent": 0.24347824, "fiftyTwoWeekRange": "1.15 - 23.8", "fiftyTwoWeekHighChange": -22.369999, "fiftyTwoWeekHighChangePercent": -0.93991596, "fiftyTwoWeekChangePercent": -66.71323, "earningsTimestamp": 1747915216, "earningsTimestampStart": 1756238400, "shortName": "Galmed Pharmaceuticals Ltd.", "longName": "Galmed Pharmaceuticals Ltd.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1748648827, "regularMarketTime": 1748635201, "exchange": "NCM", "messageBoardId": "finmb_114779940", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.43, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394717400000, "earningsTimestampEnd": 1756756800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.6, "epsForward": -1.03, "fiftyDayAverageChange": -0.019800067, "fiftyDayAverageChangePercent": -0.013657102, "twoHundredDayAverageChange": -1.535015, "twoHundredDayAverageChangePercent": -0.517709, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "Galmed Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]